GoodRx Holdings, Inc. 8-K

What Happened

• GoodRx Holdings, Inc. filed an 8-K (Item 5.02) disclosing that on March 3, 2026 the Board, per the Compensation Committee’s recommendation, approved a discretionary cash bonus of $72,918 for Romin Nabiey, the Company’s Chief Accounting Officer, for 2025 performance. The report was signed and filed on March 6, 2026 by Christopher McGinnis (CFO & Treasurer).

Key Details

• Company: GoodRx Holdings, Inc. (GDRX)
• Officer: Romin Nabiey, Chief Accounting Officer
• Action: Board approved discretionary cash bonus for 2025 performance
• Amount: $72,918
• Dates: Bonus approved March 3, 2026; 8-K filed/signed March 6, 2026

Why It Matters

• This filing provides transparency about executive compensation decisions at GoodRx. The disclosed bonus is a specific, one-time discretionary cash payment tied to 2025 performance metrics. Investors tracking governance and pay practices may view this as part of the company’s broader executive compensation and retention activity. The 8-K does not indicate any change to employment terms or additional material corporate actions.